Company: KEQU
Filing Date: 2025-07-02
Form Type: 10-K
Source: 0000055529-25-000026
Chunk: 114

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-07-02
Form: 10-K
Item: Item 1A
Chunk 114
---
4,166 420 173 4,759 Interest expense1,492 71 1,651 3,214 Earnings (loss) before income taxes19,923 4,712 (9,850)14,785 Income tax expense (benefit)4,553 1,632 (2,983)3,202 Net earnings attributable to non-controlling interest— 178 — 178 Net earnings (loss) attributable to Kewaunee Scientific Corporation15,370 2,902 (6,867)11,405 Segment assets152,569 42,085 — 194,654 Expenditures for segment assets1,954 212 — 2,166 Revenues (excluding intersegment) from customers in foreign countries7,731 61,074 — 68,805 Fiscal Year 2024Revenues from external customers$137,238 $66,517 $— $203,755 Intersegment revenues636 4,062 (4,698)— Depreciation2,524 408 193 3,125 Interest expense1,574 166 59 1,799 Earnings (loss) before income taxes15,048 6,295 (8,224)13,119 Income tax expense3,240 2,935 (12,113)(5,938)Net earnings attributable to non-controlling interest— 304 — 304 Net earnings (loss) attributable to Kewaunee Scientific Corporation11,808 3,055 3,890 18,753 Segment assets91,656 43,110 — 134,766 Expenditures for segment assets3,759 614 — 4,373 Revenues (excluding intersegment) from customers in foreign countries1,175 66,517 — 67,692 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are intended to ensure that the information required to be disclosed in our filings under the Securities Exchange Act of 1934 (the "Exchange Act") is properly and timely recorded, processed, summarized, and reported. Our management, including the Chief Executive Officer and Chief Financial Officer,